Highlights

MIDF Sector Research

Author: sectoranalyst   |   Latest post: Mon, 17 Jun 2019, 12:05 PM

 

Pharmaniaga - Seasonally Stronger Quarter

Author:   |    Publish date:


INVESTMENT HIGHLIGHTS

  • 1QFY18 earnings of RM19.6m (+11.7%yoy) came in within our and consensus expectations
  • The logistics and distribution division as well as the Indonesian’s operation recorded stronger performance
  • Declared an interim dividend of six sen per share
  • Maintain BUY with a revised TP of RM2.74 per share

Double digit earnings growth. Pharmaniaga’s 1QFY19 earnings came in at RM19.6m which met ours and consensus earnings estimates at 40.6% and 34.8% respectively. Historically, 1Q earnings contributed an average of 38.4% to the full year earnings in the past three years. The stronger 1QFY19 earnings was driven by a stronger performance from both the logistics and distribution (L&D) division as well as the Indonesian operation.

Commendable revenue growth from L&D division. Pharmaniaga’s L&D division’s business primarily constitutes of the government concession contract. This concession contributed an average of 51.0% of total revenue in the past three years. The 1QFY19 revenue and operating profit for this division registered a growth of +28.1%yoy (RM582.6m) and +26.9%yoy (RM12.6m) respectively. This is due to the stronger contribution from government hospitals.

Indonesian operation has turned profitable. Pharmaniaga’s Indonesian operation historically contributed an average of 30.0% of total revenue in the past three years. While revenue has been growing steadily, the operating profit has been affected by the weaker Indonesian Rupiah in relative to Ringgit. However, a solid growth in 1QFY19 revenue of +22.5%yoy coupled with ongoing cost optimisation effort has led to an operating profit of RM0.4m in comparison to a loss of RM0.4m in the previous year corresponding quarter.

First interim dividend declared. Pharmaniaga declared a first interim dividend of 6.0sen per share (vs 1QFY18: 5.0sen) for the quarter under review.

Source: MIDF Research - 17 May 2019

Share this
Labels: PHARMA

Related Stocks

Chart Stock Name Last Change Volume 
PHARMA 2.53 -0.02 (0.78%) 68,900 

  Be the first to like this.
 


 

267  377  497  739 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HSI-C5P 0.23+0.005 
 GREATEC 0.90+0.09 
 HSI-H6P 0.32-0.02 
 HSI-C5J 0.14-0.01 
 HSI-H6Q 0.47-0.035 
 EKOVEST 0.835+0.005 
 HSI-H6N 0.195-0.025 
 MYEG 1.39-0.05 
 HPMT 0.44-0.055 
 LAMBO 0.060.00 
Partners & Brokers